CAMP4 TherapeuticsCAMP
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 46 institutions reported holding CAMP4 Therapeutics Corp. (CAMP) in their 13F filings, up 6 from Q4 2025. 11 opened new positions and 7 sold out. The largest holders were Janus Henderson Group PLC ($27.9M), 5AM Venture Management, LLC ($25.9M) and FMR LLC ($21.8M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- CAMP4 Therapeutics Corp.
- CUSIP
- 13463J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $6.6M |
| Exits | 7 | $3.9M |
All 13F filers, Q4 2025 → Q1 2026: 3,281,209 shares bought and 1,814,388 shares sold, net +1,466,821 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| Janus Henderson Group PLC | 0.01% | No change | 6,307,636 | $27.9M |
| 5AM Venture Management, LLC | 7.19% | No change | 5,869,091 | $25.9M |
| FMR LLC | 0.00% | Add +0.3% | 4,933,432 | $21.8M |
| Vivo Capital, LLC | 1.56% | No change | 4,246,568 | $18.7M |
| Balyasny Asset Management L.P. | 0.02% | Add +8.0% | 2,632,437 | $11.6M |
| Enavate Sciences Gp, LLC | 2.75% | Reduce -27.8% | 2,190,920 | $9.7M |
| a16z Capital Management, L.L.C. | 0.73% | No change | 2,125,339 | $9.4M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Reduce -10.1% | 1,960,784 | $8.6M |
| Trails Edge Capital Partners, LP | 2.01% | Reduce -2.2% | 1,939,563 | $8.6M |
| Vanguard Capital Management LLC | 0.00% | — | 1,534,768 | $6.8M |
| Stonepine Capital Management, LLC | 5.39% | Add +507.1% | 1,389,622 | $6.1M |
| HarbourVest Partners LLC | 5.56% | No change | 1,271,948 | $5.6M |
| Silverarc Capital Management, LLC | 0.34% | New | 653,594 | $2.9M |
| BlackRock, Inc. | 0.00% | Add +17.0% | 456,371 | $2.0M |
| Geode Capital Management, LLC | 0.00% | Add +13.8% | 382,821 | $1.7M |
| SummitTX Capital, L.P. | 0.05% | New | 339,521 | $1.5M |
| Susquehanna International Group, LLP | 0.00% | New | 336,047 | $1.5M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 195,013 | $860K |
| State Street Corp. | 0.00% | Add +270.0% | 146,900 | $648K |
| Two Sigma Investments, LP | 0.00% | Add +15.2% | 108,875 | $480K |
| 683 Capital Management, LLC | 0.05% | Reduce -14.5% | 108,000 | $476K |
| Millennium Management | 0.00% | Add +750.5% | 85,918 | $379K |
| Victory Capital Management Inc. | 0.00% | Reduce -0.4% | 82,450 | $364K |
| Goldman Sachs Group Inc. | 0.00% | Add +316.2% | 78,345 | $346K |
| Northern Trust Corp. | 0.00% | Reduce -5.2% | 70,666 | $312K |
| Hudson Bay Capital Management LP | 0.00% | New | 48,511 | $214K |
| Barclays PLC | 0.00% | Reduce -52.9% | 34,693 | $153K |
| Bank of America Corp. | 0.00% | Add +141700.0% | 31,196 | $138K |
| HRT Financial LP | 0.00% | New | 30,747 | $135K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 25,000 | $110K |
| Qube Research & Technologies Ltd | 0.00% | New | 24,803 | $109K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 20,000 | $88K |
| Bank of New York Mellon Corp | 0.00% | No change | 18,718 | $83K |
| Point72 Asset Management | 0.00% | New | 17,326 | $76K |
| China Universal Asset Management Co., Ltd. | 0.01% | Add +60.0% | 16,000 | $71K |
| Diametric Capital, LP | 0.02% | New | 14,446 | $64K |
| Scientech Research LLC | 0.05% | New | 12,735 | $56K |
| Vanguard Global Advisers, LLC | 0.00% | — | 11,615 | $51K |
| Citigroup Inc. | 0.00% | Reduce -53.8% | 9,887 | $44K |
| Morgan Stanley | 0.00% | Reduce -4.1% | 9,505 | $42K |
| UBS Group AG | 0.00% | Add +76.5% | 9,081 | $40K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +246.1% | 1,405 | $6K |
| Royal Bank of Canada | 0.00% | Add +1211.1% | 236 | $1K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 74 | $326 |
| BNP Paribas Financial Markets | 0.00% | Add +9.1% | 36 | $159 |
| SBI Securities Co., Ltd. | 0.00% | No change | 10 | $44 |
"% of holder's portfolio" is CAMP's weight in each manager's 13F, not the share of CAMP4 Therapeutics Corp. the manager owns.